News
STAT+: Kyverna’s cell therapy shows lasting autoimmune benefit
Kyverna Therapeutics is one step closer to launching the first cell therapy for an autoimmune disease, with new data in hand showing many patients remained off of other therapies a…
More in Health
- Meal deliveries can save money and improve health. Will they survive Medicaid cuts? NPR — Health
- Drones could speed up getting defibrillators to people having cardiac arrests, study suggests The Guardian — Society
- U.S. Rejects U.N. Declaration on Preparing for Future Pandemics The New York Times — Health
- Trump administration uses rare authority to claw back nearly $1B in spending approved by Congress STAT
- NHS to suspend staff suspected of snooping on patient records BBC News — Health